- Conditions: Uterine Cancer; Cervical Cancer
Intervention: Radiation: Proton beam therapy
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Cancer Institute (NCI)
Active, not recruiting - verified May 2012 - Condition: HPV-16 +ve Oropharyngeal Carcinoma
Intervention: Biological: ADXS11-001
Sponsors: University of Liverpool; University of Liverpool; Aintree University Hospitals NHS Foundation Trust; Cancer Research UK; Advaxis, Inc.; Recipharm AB
Recruiting - verified May 2012 - Conditions: Human Papillomavirus; Vaginal Infection
Intervention: Dietary Supplement: U-relax
Sponsors: Chang Gung Memorial Hospital; Chang Gung Memorial Hospital
Recruiting - verified April 2012 - Conditions: Cervical Cancer; Nonneoplastic Condition
Interventions: Drug: cisplatin; Procedure: antiviral therapy; Procedure: quality-of-life assessment; Radiation: external beam radiation therapy; Radiation: intracavitary balloon brachytherapy
Sponsors: National Cancer Institute (NCI); AIDS Associated Malignancies Clinical Trials Consortium; National Cancer Institute (NCI)
Not yet recruiting - verified April 2012 - Conditions: Cervical Cancer; Oropharyngeal Cancer; Vaginal Cancer; Anal Cancer; Penile Cancer
Interventions: Drug: Fluderabine; Drug: Cycolphosphamide; Biological: Young TIL; Biological: Aldesleukin
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Lung Cancer - Malignant Pleural Mesothelioma
Interventions: Drug: Ganetespib; Drug: Placebo
Sponsors: University College, London; University College, London; Cancer Research UK
Not yet recruiting - verified May 2012 - Condition: Cervical Cancer
Intervention:
Sponsors: Meir Medical Center; Meir Medical Center
Completed - verified April 2012 - Condition: Cancer
Intervention:
Sponsors: Rambam Health Care Campus; Rambam Health Care Campus
Not yet recruiting - verified April 2012 - Condition: Carcinoma Cervix
Interventions: Drug: Paclitaxel, Cisplatin; Drug: Cisplatin
Sponsors: Indira Gandhi Medical College; Indira Gandhi Medical College
Recruiting - verified May 2012 - Conditions: Adenocarcinoma of the Gastroesophageal Junction; Cervical Cancer; Endometrial Cancer; Esophageal Cancer; Fallopian Tube Cancer; Gastric Cancer; Ovarian Cancer; Sarcoma; Vaginal Cancer; Vulvar Cancer
Intervention:
Sponsors: Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of Surrey
Recruiting - verified April 2012 - Condition: Cervical Cancer
Intervention:
Sponsors: Masonic Cancer Center, University of Minnesota; Masonic Cancer Center, University of Minnesota
Not yet recruiting - verified April 2012 - Conditions: Anal Cancer; Cervical Cancer; Lung Cancer; Lymphoma; Nonneoplastic Condition
Interventions: Genetic: DNA analysis; Genetic: RNA analysis; Genetic: gene expression analysis; Genetic: polymorphism analysis; Other: biologic sample preservation procedure; Other: flow cytometry; Other: laboratory biomarker analysis; Other: medical chart review
Sponsors: National Cancer Institute (NCI); AIDS Associated Malignancies Clinical Trials Consortium; National Cancer Institute (NCI)
Not yet recruiting - verified March 2012 - Condition: Cervical Cancer
Interventions: Drug: Paclitaxel; Drug: Carboplatin; Radiation: Radiotherapy; Drug: Cisplatin
Sponsors: University College, London; University College, London; Cancer Research UK
Not yet recruiting - verified March 2012 - Condition: Cervical Cancer
Interventions: Radiation: irradiation; Drug: Cisplatin; Drug: liposome paclitaxel
Sponsors: Xi’an Jiaotong University College of Medicine; Xi’an Jiaotong University College of Medicine
Active, not recruiting - verified May 2012 - Condition: HPV Infection
Intervention: Device: Monogin
Sponsors: AGUNCO Obstetrics and Gynecology Centre; AGUNCO Obstetrics and Gynecology Centre
Completed - verified June 2011 - Condition: Cancer
Intervention: Device: ultrasound examination
Sponsors: Rambam Health Care Campus; Rambam Health Care Campus
Not yet recruiting - verified March 2011 - Condition: Cervical Cancer
Interventions: Drug: Weekly cisplatin with RT; Drug: Tri-weekly cisplatin with RT
Sponsors: Korea Cancer Center Hospital; Korea Cancer Center Hospital; Seoul National University Hospital; Asan Medical Center; Gangnam Severance Hospital
Active, not recruiting - verified March 2012 - Condition: Uterine Cervical Neoplasms
Interventions: Behavioral: Cognitive-affective barriers counseling; Behavioral: Cognitive-affective barriers counseling via brochure; Behavioral: standard care
Sponsors: Fox Chase Cancer Center; Fox Chase Cancer Center; Temple University; National Cancer Institute (NCI)
Completed - verified March 2012 - Conditions: Breast Cancer; Cervical Cancer; Colon Cancer; Rectal Cancer; Abnormal Finding in the Breast, Cervix, or Colon and Rectum
Interventions: Behavioral: Patient Navigator matched with subject; Behavioral: Subjects are mailed informational/educational materials
Sponsors: Ohio State University Comprehensive Cancer Center; Electra Paskett; American Cancer Society
Active, not recruiting - verified March 2012 - Conditions: Cervical Cancer; Human Papillomavirus Infection
Interventions: Behavioral: Attending for cervical cytology; Behavioral: Kit for Self-collected vaginal sample
Sponsors: University Hospital, Tours; University Hospital, Tours
Enrolling by invitation - verified March 2012 - Conditions: Advanced Solid Tumor; Lymphoma
Intervention: Drug: DS-3078a
Sponsors: Daiichi Sankyo Inc.; Daiichi Sankyo Inc.
Recruiting - verified April 2012 - Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical CancerCondition: Cervical Cancer
Interventions: Radiation: Intensity Modulated Radiation Therapy (IMRT); Drug: Cisplatin
Sponsors: University of California, San Diego; University of California, San Diego; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Condition: Cervical Carcinoma
Interventions: Radiation: Intensity Modulated Radiation Therapy (IMRT); Drug: Cisplatin; Drug: Gemcitabine
Sponsors: University of California, San Diego; University of California, San Diego
Recruiting - verified March 2012 - Condition: Cervical Cancer
Intervention: Other: Blood draw
Sponsors: Stanford University; Stanford University
Recruiting - verified March 2012 - Conditions: Cervical Cancer; Cervical Intraepithelial Neoplasia; Adenocarcinoma in Situ
Intervention: Biological: V501
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: CIN2/3 Recurrence
Intervention: Other: Study Follow-Up
Sponsors: University Hospital, Bordeaux; University Hospital, Bordeaux
Recruiting - verified March 2012 - Condition: Human Papillomavirus
Interventions: Biological: HPV 16/18 vaccine, 0,5ml; Biological: Placebo control, 0.5ml; Biological: HPV 16/18 vaccine, 1.0ml; Biological: Placebo control, 1.0ml
Sponsors: Shanghai Zerun Biotechnology Co.,Ltd; Shanghai Zerun Biotechnology Co.,Ltd
Enrolling by invitation - verified March 2012 - Conditions: Cervical Cancer; Precancerous Condition
Intervention: Procedure: Self-collected at home HPV testing
Sponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Cancer of the Cervix
Interventions: Drug: Granisetron; Drug: Ondansetron; Behavioral: Questionnaires; Behavioral: Study Drug Diary
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; Sancuso
Recruiting - verified March 2012 - Conditions: Adolescent Health Services; Immunization
Intervention: Other: Assessment , Feedback, Incentives, and eXchange Program
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; North Carolina Division of Public Health
Active, not recruiting - verified February 2012 - Conditions: Uterine Neoplasms; Sentinel Lymph Node Biopsy
Intervention: Procedure: Sentinel Lymph Node Biopsy
Sponsors: Hamilton Health Sciences Corporation; Hamilton Health Sciences Corporation; Juravinski Cancer Centre Foundation
Not yet recruiting - verified March 2012 - Conditions: HPV Vaccine Attitudes; HPV Vaccine Intention
Intervention:
Sponsors: Indiana University; Indiana University; Merck
Not yet recruiting - verified February 2012 - Conditions: Glioma; Glioblastoma Multiforme; Neoplasms
Interventions: Procedure: Surgery; Drug: Chemotherapy; Radiation: Radiotherapy; Biological: DC vaccination; Drug: blank placebo
Sponsors: Huashan Hospital; Huashan Hospital; Fudan University
Recruiting - verified March 2012 - Condition: Cervical Cancer Screening
Interventions: Behavioral: DVD; Behavioral: Promotora
Sponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI)
Recruiting - verified January 2012 - Conditions: HPV6 and HPV18; Immunogenicity; HPV Vaccine; Cervical Cancer; Partial Vaccination
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified October 2011 - Conditions: Ovarian Cancer; Endometrial Cancer; Uterine Cervical Cancer
Interventions: Drug: Filgrastim; Drug: Paclitaxel; Drug: Carboplatin
Sponsors: Belgian Gynaecological Oncology Group; Belgian Gynaecological Oncology Group
Recruiting - verified March 2012 - Conditions: Cervical Cancer Squamous Cell; Human Papilloma Virus Infection; Human Papilloma Virus-Related Carcinoma; Prevention
Intervention:
Sponsors: Barretos Cancer Hospital; Barretos Cancer Hospital; QIAGEN Gaithersburg, Inc
Recruiting - verified April 2012 - Conditions: Cervical Intraepithelial Neoplasia; Cervical Cancer; Cervical Neoplasm; Cervical Dysplasia; Human Papillomavirus
Interventions: Procedure: cryotherapy; Procedure: Colposcopy
Sponsors: Preventive Oncology International, Inc.; Preventive Oncology International, Inc.; Peking University Shenzhen Hospital; BGI Shenzhen
Enrolling by invitation - verified January 2012 - Condition: Cervical Cancer
Intervention:
Sponsors: Far Eastern Memorial Hospital; Far Eastern Memorial Hospital
Recruiting - verified April 2012 - Condition: Human Papillomavirus
Intervention: Other: Collecting a Pad used at the first menstrual period after enrollment
Sponsors: Seoul National University Hospital; Seoul National University Hospital
Not yet recruiting - verified January 2012 - Condition: High-grade Cervical Intraepithelial Neoplasia
Intervention: Other: HPV testing
Sponsors: Karolinska Institutet; Karolinska Institutet; Stockholm County Council, Sweden; Cancer Screening Unit, Oncology Center, Stockholm, Sweden
Not yet recruiting - verified January 2012 - Condition: Stress Disorders, Post-Traumatic
Intervention: Procedure: Stellate ganglion block
Sponsors: Southern California Institute for Research and Education; Southern California Institute for Research and Education
Recruiting - verified February 2012 - Conditions: Stomach Neoplasms; Metaplasia
Intervention: Procedure: Acetic acid chromoendoscopy
Sponsors: Konyang University Hospital; Konyang University Hospital
Completed - verified April 2012 - Conditions: Integrated MRI Based RT as Standard of Care; Locally Advanced Cervical Cancer
Interventions: Radiation: Gold seeds insertion to detect movements at pelvis; Radiation: Image guided MRI based RT (IMRT+Brachytherapy)
Sponsors: Alberta Health Services; Alberta Health Services
Withdrawn - verified January 2012 - Condition: Cervical Cancer
Interventions: Drug: paclitaxel; Drug: Cisplatin 50mg/m2
Sponsors: Korean Gynecologic Oncology Group; Korean Gynecologic Oncology Group
Recruiting - verified December 2011 - Conditions: Human Papilloma Virus; Cervical Cancer; Cervical Intraepithelial Neoplasia
Intervention:
Sponsors: Zhejiang University; Xing Xie, MD
Recruiting - verified December 2011 - Condition: Head and Neck Cancer
Interventions: Device: bandage skin Hydrosorb; Drug: Biafine®
Sponsors: Centre Francois Baclesse; Centre Francois Baclesse; Ministry of Health, France
Recruiting - verified January 2012 - Condition: Cervical Cancer
Interventions: Drug: Nelfinavir; Drug: Cisplatin; Radiation: Pelvic External Beam Radiation Therapy; Radiation: Brachytherapy; Procedure: Pharmacokinetic Sampling; Procedure: Cervical Biopsy; Procedure: Pelvic Examination; Procedure: Pap Smear; Procedure: Audiogram; Procedure: Proctoscopy; Procedure: Cytoscopy; Procedure: Renal Ultrasound; Procedure: CT Scan; Procedure: Whole Body PET/CT Scan
Sponsors: University of Miami Sylvester Comprehensive Cancer Center; University of Miami Sylvester Comprehensive Cancer Center
Not yet recruiting - verified December 2011 - Condition: Esophageal Cancer
Interventions: Radiation: Proton Beam Therapy (PBT); Radiation: Intensity Modulated Radiation Therapy (IMRT); Behavioral: Questionnaires
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified April 2012 - Condition: Uterine Cervical Dysplasia
Interventions: Procedure: Lidocaine spray; Procedure: Lidocaine submucosal injection
Sponsors: Chiang Mai University; Chiang Mai University
Recruiting - verified January 2012 - Conditions: Tethered Spinal Cord; Brain Tumor; Cranio Cervical Compression
Intervention: Other: Isoflurane, Propofol, Dexmedetomidine
Sponsors: Oregon Health and Science University; Oregon Health and Science University
Recruiting - verified January 2012 - Condition: Cervical Cancer
Interventions: Radiation: Radiation therapy; Drug: Carboplatin; Drug: Cisplatin
Sponsors: Asan Medical Center; Asan Medical Center; Boryung Pharmaceutical Co., Ltd
Recruiting - verified October 2011 - Condition: Cervical Cancer
Intervention: Other: hyperthermia
Sponsors: Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology; Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology
Completed - verified November 2011 - Condition: Sexual Transmission of Infection
Interventions: Biological: Gardasil Vaccine; Biological: Placebo Vaccine
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; H. Lee Moffitt Cancer Center and Research Institute; Merck
Not yet recruiting - verified May 2012 - Conditions: Human Papillomavirus; HIV-1 Infection
Intervention: Biological: Gardasil vaccine
Sponsors: Kenyatta National Hospital; Nelly R. Mugo; University of Washington; Merck
Not yet recruiting - verified October 2011 - Condition: Esophageal Cancer
Intervention:
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM)
Recruiting - verified November 2011 - Condition: HPV-induced Cancers
Intervention: Biological: P16_37-63
Sponsors: Oryx GmbH & Co. KG; Oryx GmbH & Co. KG
Recruiting - verified October 2011 - Condition: Locally Advanced Nasopharyngeal Carcinoma
Interventions: Drug: Famitinib; Drug: Cisplatin; Radiation: radiation（IMRT）
Sponsors: Jiangsu HengRui Medicine Co., Ltd.; Jiangsu HengRui Medicine Co., Ltd.; Sun Yat-sen University
Recruiting - verified November 2011 - Condition: Multiple Sclerosis
Intervention: Other: NA-NOSE artificial olfactory system
Sponsors: Carmel Medical Center; Carmel Medical Center; Technion, Israel Institute of Technology
Recruiting - verified March 2012 - Condition: Cervical Cancer
Intervention:
Sponsors: Xi’an Jiaotong University College of Medicine; Xi’an Jiaotong University College of Medicine
Recruiting - verified March 2012 - Conditions: Cervical Cancer; Chemotherapeutic Agent Toxicity; Cognitive/Functional Effects; Psychosocial Effects of Cancer and Its Treatment; Radiation Toxicity; Sexuality and Reproductive Issues
Interventions: Drug: carboplatin; Drug: cisplatin; Drug: paclitaxel
Sponsors: National Cancer Institute (NCI); Gynecologic Oncology Group; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Cervical Cancer; LSIL
Intervention:
Sponsors: Ikonisys, Inc.; Ikonisys, Inc.
Enrolling by invitation - verified August 2011 - Condition: Lung Cancer
Intervention: Procedure: Cervical mediastinoscopy
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM)
Recruiting - verified September 2011 - Conditions: Radiation Enteritis; Radiation Proctitis
Interventions: Dietary Supplement: FructoOligoSaccharide; Dietary Supplement: Maltodextrin
Sponsors: University College London Hospitals; University College London Hospitals
Recruiting - verified August 2010 - Condition: Recurrent, Persistent or Metastasized Cervical Cancer
Interventions: Drug: Paclitaxel; Drug: Cisplatin/Paclitaxel
Sponsors: Institut fuer Frauengesundheit; Institut fuer Frauengesundheit; GlaxoSmithKline; Schantl Pharma Service, Germany
Active, not recruiting - verified September 2006 - Condition: Cervical Dysplasia
Intervention: Procedure: Curette v/s endocervical brush
Sponsors: University Hospital, Geneva; University Hospital, Geneva
Enrolling by invitation - verified September 2011 - Conditions: Endometrial Cancer; Cervical Cancer
Intervention: Drug: Tachosil fibrin patch
Sponsors: Ruhr University of Bochum; Ruhr University of Bochum
Recruiting - verified November 2011 - Conditions: Colorectal Cancer; Breast Cancer; Cervical Cancer
Interventions: Behavioral: IVR only; Behavioral: IVR+PCC
Sponsors: Harvard School of Public Health; Harvard School of Public Health; National Cancer Institute (NCI)
Active, not recruiting - verified July 2011 - Conditions: Cervical Cancer; Uterine Cancer; Vaginal Cancer; Carcinoma of the Vulva
Intervention: Procedure: Image-guided brachytherapy
Sponsors: Dana-Farber Cancer Institute; Dana-Farber Cancer Institute
Recruiting - verified February 2012 - Condition: Uterine Cervical Cancer
Intervention: Procedure: Screening for cervical cancer
Sponsors: University of Tampere; University of Tampere; FinnMedi Oy; GlaxoSmithKline
Enrolling by invitation - verified April 2011 - Condition: Cervical Cancer
Intervention: Radiation: MR PET Guided Brachytherapy
Sponsors: Tata Memorial Hospital; Tata Memorial Hospital
Recruiting - verified June 2011 - Conditions: Cervical Cancer; Human Papilloma Virus Infection
Intervention: Device: Electrosensing antibody probing system (e- Ab sensor)
Sponsors: National Taiwan University Hospital; National Taiwan University Hospital
Recruiting - verified June 2010 - Conditions: Renal Cell Carcinoma; Soft Tissue Sarcoma; Glioblastoma; Ovarian Cancer; Cervical Cancer; Breast Cancer; Non-small Cell Lung Cancer; Small Cell Lung Cancer; Pancreatic Cancer; Melanoma; Gastrointestinal Cancer
Intervention: Drug: Pazopanib
Sponsors: Cambridge University Hospitals NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; University of Cambridge; GlaxoSmithKline; Cambridge Experimental Cancer Medicine Centre
Recruiting - verified June 2011 - Condition: Cervical Cancer
Intervention:
Sponsors: University Hospital for Infectious Diseases, Croatia; University Hospital for Infectious Diseases, Croatia; Merck
Recruiting - verified June 2011 - Condition: Cervix Cancer
Intervention: Procedure: 18F-Fluoroazomycin Arabinoside (18F-FAZA)
Sponsors: University Health Network, Toronto; University Health Network, Toronto
Recruiting - verified March 2012 - Condition: Human Papillomavirus Infection
Intervention: Biological: CervarixTM (GSK580299)
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Not yet recruiting - verified February 2012 - Conditions: Cervical Cancer; HPV Type 16/18 Infections
Intervention: Biological: GSK Biologicals' HPV vaccine 580299
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Active, not recruiting - verified March 2012 - Condition: Uterine Cervical Dysplasia
Intervention: Drug: sodium bicarbonate buffered lidocaine
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Recruiting - verified October 2011 - Condition: Cancer
Interventions: Drug: prasterone; Other: placebo
Sponsors: National Cancer Institute (NCI); North Central Cancer Treatment Group; National Cancer Institute (NCI)
Recruiting - verified February 2012 - Condition: Uterine Cervical Neoplasms
Intervention: Other: Different alternatives to improve the coverage of the populational screening programmes of cervical cancer
Sponsors: Jordi Gol i Gurina Foundation; Jordi Gol i Gurina Foundation
Recruiting - verified June 2011 - Conditions: Cervical Cancer; Cervical Intraepithelial Neoplasia II; Cervical Intraepithelial Neoplasia III
Intervention:
Sponsors: Onconix,Inc; Onconix,Inc
Enrolling by invitation - verified June 2011 - Conditions: Breast Cancer; Colorectal Cancer; Cervical Cancer
Intervention: Other: TopCare: Use of provider knowledge vs. automated system
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Active, not recruiting - verified June 2011 - Condition: Cervical Cancer
Intervention: Behavioral: Lay health advisor visits and newsletter
Sponsors: University of Kentucky; University of Kentucky; National Cancer Institute (NCI)
Completed - verified June 2011 - Conditions: Lung Cancer; Cervical Cancer; Breast Cancer; Colorectal Cancer
Intervention: Behavioral: Lay health advisor interactions
Sponsors: University of Kentucky; University of Kentucky; National Center on Minority Health and Health Disparities (NCMHD)
Enrolling by invitation - verified June 2011 - Conditions: Cervical Squamous Cell Carcinoma; Adenosquamous Carcinoma; Adenocarcinoma; Locally Advanced Malignant Neoplasm; Cervical Cancer
Interventions: Procedure: Extraperitoneal laparoscopic lymphadenectomy (EPLND); Radiation: Chemoradiation
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center
Recruiting - verified February 2012 - Conditions: Uterine Cancer; Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer; Cervical Cancer; Vulvar Cancer
Intervention: Other: Survey
Sponsors: Abramson Cancer Center of the University of Pennsylvania; Abramson Cancer Center of the University of Pennsylvania
Recruiting - verified June 2011 - Conditions: Lymphadenopathy; Malignancy
Intervention:
Sponsors: Far Eastern Memorial Hospital; Far Eastern Memorial Hospital
Completed - verified May 2011 - Conditions: Thyroid Cancer; Recurrence
Intervention:
Sponsors: Korean Association of Endocrine Surgeons; Korean Association of Endocrine Surgeons
Recruiting - verified January 2011 - Conditions: Human Papillomavirus; CIN 2; CIN 3
Intervention: Other: No intervention; observational study
Sponsors: University of California, San Francisco; University of California, San Francisco; National Institutes of Health (NIH); National Cancer Institute (NCI)
Active, not recruiting - verified April 2011 - Condition: Squamous Papilloma of the Larynx
Intervention: Biological: Silgard
Sponsors: Institute of Hematology and Blood Transfusion, Czech Republic; Ruth Tachezy, PhD.; Medical Healthcom Prague; Na Homolce Hospital Prague
Recruiting - verified January 2012
 |
Join Clinical Trials in Calgary Canada |
